Nov 9, 2022 04:03PM
Aug 8, 2022 08:05AM
Aug 8, 2022 08:00AM
Jul 20, 2022 04:00PM
May 4, 2022 08:06AM
May 4, 2022 08:05AM
May 4, 2022 08:00AM Clovis Oncology Announces First Quarter 2022 Operating Results and Provides Update on Clinical Development Programs
Apr 20, 2022 08:00AM
Feb 23, 2022 08:09AM
Feb 23, 2022 08:05AM
Feb 10, 2022 04:05PM
Jan 10, 2022 08:00AM
Jan 10, 2022 08:00AM
Nov 3, 2021 08:11AM Clovis Oncology (CLVS) Misses Q3 EPS by 8c; Reports $171.9M in Cash and Cash Equivalents
Nov 3, 2021 08:00AM
Oct 20, 2021 08:00AM
Aug 4, 2021 08:04AM
Aug 4, 2021 08:00AM
Jul 21, 2021 08:00AM
May 5, 2021 12:21PM
May 5, 2021 08:12AM Clovis Oncology (CLVS) Tops Q1 EPS by 8c
May 5, 2021 08:00AM
Apr 21, 2021 04:00PM
Feb 23, 2021 01:02PM
Feb 23, 2021 08:02AM
Feb 23, 2021 08:00AM
Feb 17, 2021 08:00AM
Jan 11, 2021 08:11AM Clovis Oncology (CLVS) Announces Preliminary Product Revenues for Q4
Jan 11, 2021 08:00AM
Nov 5, 2020 08:18AM
Nov 5, 2020 08:05AM
Oct 20, 2020 04:05PM
Aug 6, 2020 04:05PM
Jul 23, 2020 08:00AM
May 5, 2020 04:44PM Clovis Oncology (CLVS) Misses Q1 EPS by 12c
May 5, 2020 04:05PM
Apr 21, 2020 04:05PM
Feb 25, 2020 09:21AM
Feb 24, 2020 05:57PM
Feb 24, 2020 04:14PM
Feb 24, 2020 04:05PM
Feb 13, 2020 08:30AM Clovis Oncology to Announce Fourth Quarter/Full Year 2019 Financial Results and Host Webcast Conference Call on February 24
Jan 15, 2020 09:17AM
Jan 7, 2020 07:28AM
Jan 7, 2020 07:25AM
Nov 7, 2019 08:03AM
Nov 7, 2019 08:00AM
Oct 22, 2019 08:30AM
Sep 23, 2019 05:51AM Clovis Oncology (CLVS) Reports Acquisition of Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals
Sep 23, 2019 04:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All